TuHURA BIOSCIENCES, INC./NV Deferred Tax Assets, Operating Loss Carryforwards
TuHURA BIOSCIENCES, INC./NV (HURA) had Deferred Tax Assets, Operating Loss Carryforwards of $94.38 million as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-31
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $94.38M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $25.10M.
- 2024-06-30: Deferred Tax Assets, Operating Loss Carryforwards $27.91M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $11.14M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $94.38M 10-K · filed 2026-03-31 | |
| 2024-12-31 | $25.10M 10-K · filed 2026-03-31 | |
| 2024-06-30 | $27.91M 10-K · filed 2024-10-07 | |
| 2023-12-31 | $11.14M 10-K · filed 2025-03-31 | |
| 2023-06-30 | $29.20M 10-K · filed 2024-10-07 | |
| 2022-06-30 | $25.54M 10-K · filed 2023-09-18 | |
| 2021-06-30 | $20.15M 10-K · filed 2022-09-27 | |
| 2020-06-30 | $11.87M 10-K · filed 2021-09-28 | $11.87M 10-K · filed 2020-09-18 |
| 2019-06-30 | $10.82M 10-K · filed 2020-09-18 | |
| 2018-06-30 | $9.42M 10-K · filed 2019-09-09 | |
| 2017-06-30 | $7.34M 8-K · filed 2019-06-03 | |
| 2016-06-30 | $5.00M 10-K · filed 2017-09-27 | |
| 2015-06-30 | $4.34M 10-K · filed 2016-09-13 | |
| 2014-06-30 | $2.69M 10-K · filed 2015-11-16 | |
| 2013-12-31 | $1.82M 10-K · filed 2014-08-28 | |
| 2012-12-31 | $323.91K 10-K · filed 2014-08-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |